• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

筛查性与症状性结直肠癌患者的生存结局。

Survival outcome of patients with screening versus symptomatically detected colorectal cancers.

机构信息

Department of Colorectal Surgery, University Hospital Coventry, Coventry, UK.

出版信息

Colorectal Dis. 2013 Jan;15(1):74-9. doi: 10.1111/j.1463-1318.2012.03120.x.

DOI:10.1111/j.1463-1318.2012.03120.x
PMID:22672571
Abstract

AIM

The national Bowel Cancer Screening Programme has been rolled out nationwide following pilot screening in two health authorities in the UK. The aim of this study was to define overall 5-year survival of screen detected cancers and to compare the overall survival outcome of screened vs symptomatic patients over a 10-year period.

METHOD

All patients with colorectal cancer treated at one trust in patients of screening age (50-69 years) during the pilot screening programme (2000-2008) were analysed. Patients were defined as screen detected or symptomatically detected. Disease pathology and recurrence data were obtained from the hospital's computerized results reporting system and mortality was cross-matched with data from the West Midlands Cancer Intelligence Network.

RESULTS

In all, 633 patients aged 50-69 were identified in the study period; 155 patients had a screen detected cancer and 478 did not. A log-rank test completed on survival outcomes indicated that survival was significantly worse in the symptomatic group. This difference persisted if only patients treated with curative intent were considered.

CONCLUSION

Survival outcome was significantly better in the screened vs the symptomatic population in all groups and also in those treated for curative intent. There was a trend towards better survival for screen detected cancer when compared stage for stage.

摘要

目的

英国在两个卫生部门进行试点筛查后,全国范围内推出了国家结直肠癌筛查计划。本研究的目的是定义筛查发现癌症的总体 5 年生存率,并比较 10 年内筛查患者与症状患者的总体生存结果。

方法

分析了在试点筛查计划(2000-2008 年)期间,一个信托机构中所有处于筛查年龄(50-69 岁)的结直肠癌患者。患者被定义为筛查发现或症状发现。疾病病理和复发数据来自医院的计算机化结果报告系统,死亡率与西米德兰兹癌症情报网络的数据交叉匹配。

结果

在研究期间,共确定了 633 名 50-69 岁的患者;155 名患者患有筛查发现的癌症,478 名患者没有。生存结果的对数秩检验表明,症状组的生存率明显较差。如果只考虑有治愈意图治疗的患者,这种差异仍然存在。

结论

在所有组中,筛查组与症状组的生存结果明显优于症状组,在有治愈意图治疗的患者中也是如此。与分期相比,筛查发现的癌症有更好的生存趋势。

相似文献

1
Survival outcome of patients with screening versus symptomatically detected colorectal cancers.筛查性与症状性结直肠癌患者的生存结局。
Colorectal Dis. 2013 Jan;15(1):74-9. doi: 10.1111/j.1463-1318.2012.03120.x.
2
Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends.英国结直肠癌筛查试点研究对发病率、分期分布和死亡率趋势的影响。
Cancer Epidemiol. 2012 Aug;36(4):e232-42. doi: 10.1016/j.canep.2012.02.006. Epub 2012 Mar 14.
3
Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines.与通过两周疑似结直肠癌转诊指南诊断的癌症相比,通过筛查发现的结直肠癌患者的癌症特异性生存率得到了提高。
Colorectal Dis. 2013 Feb;15(2):177-82. doi: 10.1111/j.1463-1318.2012.03131.x.
4
Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.在意大利北部,免疫化学粪便潜血试验筛查发现的结直肠癌患者与非筛查发现的患者相比,5年生存率有所提高。
Dig Liver Dis. 2015 Jan;47(1):68-72. doi: 10.1016/j.dld.2014.09.015. Epub 2014 Oct 8.
5
Impact of the bowel-screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran.阿盖尔和阿伦郡的肠癌筛查项目对结直肠癌诊断的影响。
Colorectal Dis. 2013 Jan;15(1):34-41. doi: 10.1111/j.1463-1318.2012.03100.x.
6
Impact of the United Kingdom national bowel cancer awareness campaigns 2012 on colorectal cancer services and patient survival.2012年英国全国肠癌宣传活动对结直肠癌服务及患者生存率的影响
Colorectal Dis. 2015 Dec;17(12):1055-61. doi: 10.1111/codi.13038.
7
Impact of bowel cancer screening on the management of colorectal cancer.肠癌筛查对结直肠癌管理的影响。
Colorectal Dis. 2014 Jun;16(6):450-8. doi: 10.1111/codi.12562.
8
The association between referral source and outcome in patients with colorectal cancer.结直肠癌患者转诊来源与结局的关系。
Surgeon. 2013 Jun;11(3):141-6. doi: 10.1016/j.surge.2012.10.004. Epub 2012 Dec 11.
9
Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.基于粪便潜血试验的结直肠癌人群筛查项目中的间期癌:对分期、性别和肿瘤部位的影响。
Gut. 2012 Apr;61(4):576-81. doi: 10.1136/gutjnl-2011-300535. Epub 2011 Sep 19.
10
Impact of the United kingdom national bowel cancer awareness campaign on colorectal services.英国国家结直肠癌宣传活动对结直肠服务的影响。
Dis Colon Rectum. 2014 Jan;57(1):70-5. doi: 10.1097/01.dcr.0000437689.19579.97.

引用本文的文献

1
Proportion and characteristics of screen-detected and non-screen-detected colo-rectal cancers in Germany.德国筛查和非筛查结直肠癌的比例和特征。
Acta Oncol. 2024 Nov 24;63:924-931. doi: 10.2340/1651-226X.2024.40234.
2
Prognostic Study of Colorectal Cancer: Differences between Screen-Detected and Symptom-Diagnosed Patients.结直肠癌的预后研究:筛查发现与症状诊断患者之间的差异
Cancers (Basel). 2024 Sep 30;16(19):3363. doi: 10.3390/cancers16193363.
3
Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries.
欧洲国家筛查发现的结直肠癌患者的总体生存率和特定分期生存率:一项基于9个国家人群的研究。
Lancet Reg Health Eur. 2022 Jul 6;21:100458. doi: 10.1016/j.lanepe.2022.100458. eCollection 2022 Oct.
4
More Favorable Short and Long-Term Outcomes for Screen-Detected Colorectal Cancer Patients.筛查发现的结直肠癌患者的短期和长期预后更有利。
Front Oncol. 2021 Mar 15;11:620644. doi: 10.3389/fonc.2021.620644. eCollection 2021.
5
Colorectal Adenomas-Genetics and Searching for New Molecular Screening Biomarkers.结直肠腺瘤——遗传学及新型分子筛查生物标志物的探索。
Int J Mol Sci. 2020 May 5;21(9):3260. doi: 10.3390/ijms21093260.
6
Gender- and Race-Based Differences in Barriers and Facilitators to Early Detection of Colon Cancer.性别和种族差异对结肠癌早期检测的障碍和促进因素。
J Womens Health (Larchmt). 2020 Sep;29(9):1192-1202. doi: 10.1089/jwh.2019.8163. Epub 2020 Feb 25.
7
Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.提高澳大利亚国家结直肠癌筛查计划的参与度和投资效益,改善其结果。
PLoS One. 2020 Feb 3;15(2):e0227899. doi: 10.1371/journal.pone.0227899. eCollection 2020.
8
Cost-utility of colorectal cancer screening at 40 years old for average-risk patients.40岁平均风险患者的结直肠癌筛查的成本效益
Prev Med. 2020 Jan 27;133:106003. doi: 10.1016/j.ypmed.2020.106003.
9
Impact of socioeconomic deprivation on short-term outcomes and long-term overall survival after colorectal resection for cancer.社会经济剥夺对结直肠癌术后短期结局和长期总体生存的影响。
Int J Colorectal Dis. 2019 Dec;34(12):2101-2109. doi: 10.1007/s00384-019-03431-x. Epub 2019 Nov 12.
10
Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.马尼托巴省温尼伯市采用 Hemoccult Sensa 检测法诊断结直肠癌患者的结直肠癌间期发生率和生存情况与检测模式相关。
PLoS One. 2018 Sep 4;13(9):e0203321. doi: 10.1371/journal.pone.0203321. eCollection 2018.